Publications by authors named "Lorena M Coria"

Claim this Profile
C
Correction: Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations.
Lorena M Coria, Celeste Pueblas Castro, Laura Bruno, Helder I Nakaya, Karina A Pasquevich

Front Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations.
Lorena M Coria, Celeste Pueblas Castro, Laura Bruno, Helder I Nakaya, Karina A Pasquevich

Front Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of bivalent RBD adapted COVID-19 vaccines for broad sarbecovirus immunity.
Laura A Bruno, Celeste Pueblas Castro, Agostina Demaría, Lineia Prado, Clara G Fascetto Cassero, Lorena M Coria

NPJ Vaccines· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II/III, randomized clinical trial.
Gonzalo Perez Marc, Lorena M Coria, Ana Ceballos, Juan Manuel Rodriguez, Mónica E Lombardo

Vaccine· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ecotin protects Salmonella Typhimurium against the microbicidal activity of host proteases.
Lucas Saposnik, Lorena M Coria, Laura Bruno, Francisco F Guaimas, Julieta Pandolfi

PLoS Pathog· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A vaccine candidate based on baculovirus displaying chikungunya virus E1-E2 envelope confers protection against challenge in mice.
Ana J Caillava, Victoria Alfonso, Malena Tejerina Cibello, María Agostina Demaria, Lorena M Coria

J Virol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection.
Lorena M Coria, Juan Manuel Rodriguez, Agostina Demaria, Laura A Bruno, Mayra Rios Medrano

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults.
Karina A Pasquevich, Lorena M Coria, Ana Ceballos, Bianca Mazzitelli, Juan Manuel Rodriguez

Nat Commun· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A disordered region retains the full protease inhibitor activity and the capacity to induce CD8 T cells of the oral vaccine adjuvant U-Omp19.
M Laura Darriba, Celeste Pueblas Castro, Lorena M Coria, Laura Bruno, M Laura Cerutti

Comput Struct Biotechnol J· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice.
Lorena M Coria, Lucas M Saposnik, Celeste Pueblas Castro, Eliana F Castro, Laura A Bruno

Front Immunol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omp19 Enables to Evade the Antimicrobial Activity From Host's Proteolytic Defense System.
Karina A Pasquevich, Marianela V Carabajal, Francisco F Guaimas, Laura Bruno, Mara S Roset, Lorena M Coria

Front Immunol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge.
Lorena M Coria, Franco L Martinez, Laura A Bruno, Karina A Pasquevich, Juliana Cassataro

Vaccine· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier.
Lorena M Coria, Gabriela S Risso, Francisco F Guaimas, Mariana C Ferrero, Laura Bruno

J Control Release· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
U-Omp19 from Is a Useful Adjuvant for Vaccine Formulations against Infection in Mice.
Gabriela S Risso, Marianela V Carabajal, Laura A Bruno, Andrés E Ibañez, Lorena M Coria

Front Immunol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Brucella spp. Protease Inhibitor Limits Antigen Lysosomal Proteolysis, Increases Cross-Presentation, and Enhances CD8+ T Cell Responses.
Lorena M Coria, Andrés E Ibañez, Mercedes Tkach, Florencia Sabbione, Laura Bruno

J Immunol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brucella abortus Omp19 recombinant protein subcutaneously co-delivered with an antigen enhances antigen-specific T helper 1 memory responses and induces protection against parasite challenge.
Lorena M Coria, Andrés E Ibañez, Karina A Pasquevich, Paula L González Cobiello, Fernanda M Frank

Vaccine· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bacterial protease inhibitor protects antigens delivered in oral vaccines from digestion while triggering specific mucosal immune responses.
Andrés Esteban Ibañez, Lorena Mirta Coria, Marianela Verónica Carabajal, María Victoria Delpino, Gabriela Sofía Risso

J Control Release· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlipidated outer membrane protein Omp16 (U-Omp16) from Brucella spp. as nasal adjuvant induces a Th1 immune response and modulates the Th2 allergic response to cow's milk proteins.
Andrés E Ibañez, Paola Smaldini, Lorena M Coria, María V Delpino, Lucila G G Pacífico

PLoS One· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brucella abortus induces TNF-α-dependent astroglial MMP-9 secretion through mitogen-activated protein kinases.
M Cruz Miraglia, Romina Scian, Clara García Samartino, Paula Barrionuevo, Ana M Rodriguez, Lorena M Coria

J Neuroinflammation· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brucella abortus induces apoptosis of human T lymphocytes.
Lis N Velásquez, M Victoria Delpino, Andrés E Ibañez, Lorena M Coria, M Cruz Miraglia

Microbes Infect· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brucella abortus inhibits IFN-γ-induced FcγRI expression and FcγRI-restricted phagocytosis via toll-like receptor 2 on human monocytes/macrophages.
Paula Barrionuevo, M Victoria Delpino, Lis N Velásquez, Clara García Samartino, Lorena M Coria

Microbes Infect· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice.
Karina A Pasquevich, Andrés E Ibañez, Lorena M Coria, Clara García Samartino, Silvia M Estein

PLoS One· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis.
Karina A Pasquevich, Clara García Samartino, Lorena M Coria, Silvia M Estein, Astrid Zwerdling

J Immunol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams.
Silvia M Estein, María A Fiorentino, Fernando A Paolicchi, María Clausse, Jorge Manazza, Lorena M Coria

Vaccine· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Karina A Pasquevich, Silvia M Estein, Clara García Samartino, Astrid Zwerdling, Lorena M Coria

Infect Immun· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis